MGI Tech Co., Ltd. (688114.SH) officially integrates AI technology into life science tools, with the morning session seeing a maximum increase of over 11%.

Recently, driven by DeepSeek, the AI application sector continues to be hot. Among them, the medical information direction in the A-share market has shown impressive performance. MGI Tech Co., Ltd. (688114.SH) recently announced the official launch of its laboratory intelligent automation GLI business, fully integrating AI artificial intelligence technology into the field of life science tools. It is reported that the GLI business has upgraded the company's original "laboratory automation business" with intelligent technology, aiming to help traditional laboratory automation users break through the bottleneck of data-algorithm mutual nourishment, faster implement laboratory software and hardware, and overall operational effects, and accelerate the realization of the unlimited potential of "AI + life science." Currently, the results of the GLI business have been applied in laboratories including the Beijing Brain Gene Center and Shanghai Jiao Tong University. The GLI business has introduced laboratory AI intelligent tools and Siasun Robot & Automation technology, standardized the software and hardware systems, instrument equipment, and reagent consumables needed by life science laboratories according to laboratory functions and customized workflow requirements, forming a series of powerful functional module libraries including advanced AI intelligence tools modules, general automation equipment modules, data computing and storage modules, and ecological hardware modules. This helps laboratory users in the field of life science quickly acquire platform-based reusable "AI+" application integration capabilities. In fact, MGI Tech Co., Ltd. laid out the combination of AI and business applications many years ago and published multiple research and development achievements in authoritative journals. In August 2022, the research team of MGI Tech Co., Ltd. published a multimodal single-cell algorithm based on contrastive learning in a sub-journal of Nature, which can quickly achieve modeling of multimillion-level single-cell multi-omics data; in July 2023, the team of Yang Meng of MGI Tech Co., Ltd. published an algorithm model called "EvoPlay" in a sub-journal of Nature, which can efficiently design functional proteins using reinforcement learning algorithms. In addition, in the field of smart laboratories, relying on its independently developed automation platform, digital management system, and artificial intelligence technology, MGI Tech Co., Ltd. successfully created self-driven unmanned laboratory "Lab Smart Laboratory." In September 2024, MGI Tech Co., Ltd. launched the Lab Studio intelligent laboratory management platform, integrating cutting-edge automation technology and artificial intelligence technology, aiming to provide efficient and intelligent laboratory management solutions for global life science research and help achieve "self-driving" life science experiments. Based on the catalysts such as direct competitors Yomina being included in the Ministry of Commerce's unreliable entity list, as well as many favorable factors such as AI medical applications and high-quality fundamentals, MGI Tech Co., Ltd. has increased its market value by over 10 billion in just 4 trading days after the Spring Festival. In the investment field, various authoritative institutions are also optimistic about the investment opportunities in AI healthcare, with "Cathy Wood" emphasizing that healthcare is the most underestimated AI application. Founders also point out that domestic companies accelerating their AI layout promote research efficiency improvement and cost optimization, and continue to be bullish on the revolutionary potential of AI + medical. As of the close of the morning on February 12th, MGI Tech Co., Ltd. had the highest increase of 11.02%, and was newly added to the list of constituent stocks of the MSCI China A-share onshore index in the morning.